Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Program of vascular evaluation under glucose control by DPP-4 inhibitor.

Next Previous
Trial Profile

Program of vascular evaluation under glucose control by DPP-4 inhibitor.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sitagliptin (Primary) ; Antihyperglycaemics
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms PROLOGUE

Most Recent Events

  • 01 Feb 2019 Results from an an exploratory post hoc analysis of the PROLOGUE study using subgroups stratified by use of concomitant antidiabetic agents published in the Heart and Vessels
  • 15 May 2017 Status changed from active, no longer recruiting to completed.
  • 16 Nov 2016 Results of sub analysis assessing effect of sitagliptin on echocardiographic systolic and diastolic parameters and N-terminal pro brain natriuretic peptide, presented at the 89th Annual Scientific Sessions of the American Heart Association

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top